Skip to main content

Table 1 Baseline characteristics

From: High prevalence of peripheral arterial disease (PAD) in incident hemodialysis patients: screening by ankle-brachial index (ABI) and skin perfusion pressure (SPP) measurement

  All patients (N = 185)
Age (years) 70 (61–78)
Male, n (%) 130 (70.2)
Hypertension, n (%) 148 (80.0)
Diabetes mellitus, n (%) 100 (54.1)
Dyslipidemia, n (%) 80 (43.2)
Ischemic heart disease, n (%) 74 (40.0)
Stroke, n (%) 27 (14.9)
ABI 1.18 (1.05–1.27)
SPP (mmHg) 73 (52–85)
Previous history of PAD, n (%) 13 (7.0)
Medications
 Cilostazol, n (%) 11 (5.9)
 Sarpogrelate, n (%) 1 (0.5)
 Aspirin, n (%) 48 (25.9)
 Prostaglandin analogue, n (%) 17 (9.2)
 Ticlopidine, n (%) 18 (9.7)
 Clopidogrel, n (%) 1 (0.5)
 Warfarin, n (%) 6 (3.2)
 Dipyridamole, n (%) 10 (4.9)
 Dilazep, n (%) 9 (5.4)
ARB, n (%) 74 (40.0)
 Statin, n (%) 60 (32.4)
  1. Data are presented as median (interquartile range)
  2. ABI ankle brachial pressure index, SPP skin perfusion pressure, PAD peripheral arterial disease, ARB angiotensinII receptor blocker